· Raw material customization plan

The Meisaitai biological raw material development platform covers multiple expression systems, and based on reagent development experience, antigen antibodies that meet the platform's usage needs are selected to assist the client's research and development team in quickly completing product development.

· Reagent customization plan (OEM reagents)

Meisaitai Biotechnology has developed dozens of reagent products such as the Infection Series (HBP/PCT/IL-6) and the Cardiovascular and Cerebrovascular Series (MYO/CTNL), and can also undertake customization of new reagent products beyond the above projects.

· Reagent Customization Plan - Localized Production of Process Transfer Experiments

Meisaitai Biotechnology can provide comprehensive process transformation services. For projects that customers are interested in, we can provide "one-on-one" on-site services to achieve localized production.